APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Synthesis

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Selected research

Market Outlook & Growth Opportunities

Global Gene Synthesis Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchGene Synthesis Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Synthesis Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Gene Synthesis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Synthesis Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Synthesis Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Market competition is intense between top 5. Genescript, GeneArt (Thermofischer), IDT, DNA 2.0 (ATUM) and OriGene are the top 5 leaders of the industry, with about 76% market shares.

This report provides an overview of the global Gene Synthesis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Gene Synthesis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Synthesis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Synthesis market.

Gene Synthesis Segment by Company

Genescript

GeneArt (Thermofischer)

IDT

DNA 2.0 (ATUM)

OriGene

BBI

Genewiz

Eurofins Genomics

Gene Oracle

SBS Genetech

Bio Basic

Gene Synthesis Segment by Type

Below 1000 bp

1001-3000 bp

3001-5000 bp

Above 5000 bp

Gene Synthesis Segment by Application

Commercial Research

Academic Research

Gene Synthesis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gene Synthesis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gene Synthesis key companies, revenue, market share, and recent developments.

3. To split the Gene Synthesis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gene Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gene Synthesis significant trends, drivers, influence factors in global and regions.

6. To analyze Gene Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Synthesis industry.

Chapter 3: Detailed analysis of Gene Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gene Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gene Synthesis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gene Synthesis Industry Trends Table 2. Gene Synthesis Industry Drivers Table 3. Gene Synthesis Industry Opportunities and Challenges Table 4. Gene Synthesis Industry Restraints Table 5. Global Gene Synthesis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gene Synthesis Revenue Share by Company (2021-2026) Table 7. Global Gene Synthesis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gene Synthesis Key Company Manufacturing Base & Headquarters Table 9. Global Gene Synthesis Company, Product Type & Application Table 10. Global Gene Synthesis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gene Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Below 1000 bp Table 15. Significant Companies of 1001-3000 bp Table 16. Significant Companies of 3001-5000 bp Table 17. Significant Companies of Above 5000 bp Table 18. Global Gene Synthesis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Gene Synthesis Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Gene Synthesis Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Gene Synthesis Sales Value Share by Type (2021-2026) Table 22. Global Gene Synthesis Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Commercial Research Table 24. Significant Companies of Academic Research Table 25. Global Gene Synthesis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Synthesis Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Gene Synthesis Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Gene Synthesis Sales Value Share by Application (2021-2026) Table 29. Global Gene Synthesis Sales Value Share by Application (2027-2032) Table 30. Global Gene Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Synthesis Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Gene Synthesis Sales Value Share by Region (2021-2026) Table 33. Global Gene Synthesis Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Gene Synthesis Sales Value Share by Region (2027-2032) Table 35. Global Gene Synthesis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gene Synthesis Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Gene Synthesis Sales Value Market Share by Country (2021-2026) Table 38. Global Gene Synthesis Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Gene Synthesis Sales Value Market Share by Country (2027-2032) Table 40. Genescript Company Information Table 41. Genescript Business Overview Table 42. Genescript Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Genescript Gene Synthesis Product Portfolio Table 44. Genescript Recent Development Table 45. GeneArt (Thermofischer) Company Information Table 46. GeneArt (Thermofischer) Business Overview Table 47. GeneArt (Thermofischer) Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. GeneArt (Thermofischer) Gene Synthesis Product Portfolio Table 49. GeneArt (Thermofischer) Recent Development Table 50. IDT Company Information Table 51. IDT Business Overview Table 52. IDT Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. IDT Gene Synthesis Product Portfolio Table 54. IDT Recent Development Table 55. DNA 2.0 (ATUM) Company Information Table 56. DNA 2.0 (ATUM) Business Overview Table 57. DNA 2.0 (ATUM) Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. DNA 2.0 (ATUM) Gene Synthesis Product Portfolio Table 59. DNA 2.0 (ATUM) Recent Development Table 60. OriGene Company Information Table 61. OriGene Business Overview Table 62. OriGene Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. OriGene Gene Synthesis Product Portfolio Table 64. OriGene Recent Development Table 65. BBI Company Information Table 66. BBI Business Overview Table 67. BBI Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BBI Gene Synthesis Product Portfolio Table 69. BBI Recent Development Table 70. Genewiz Company Information Table 71. Genewiz Business Overview Table 72. Genewiz Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Genewiz Gene Synthesis Product Portfolio Table 74. Genewiz Recent Development Table 75. Eurofins Genomics Company Information Table 76. Eurofins Genomics Business Overview Table 77. Eurofins Genomics Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eurofins Genomics Gene Synthesis Product Portfolio Table 79. Eurofins Genomics Recent Development Table 80. Gene Oracle Company Information Table 81. Gene Oracle Business Overview Table 82. Gene Oracle Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Gene Oracle Gene Synthesis Product Portfolio Table 84. Gene Oracle Recent Development Table 85. SBS Genetech Company Information Table 86. SBS Genetech Business Overview Table 87. SBS Genetech Gene Synthesis Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. SBS Genetech Gene Synthesis Product Portfolio Table 89. SBS Genetech Recent Development Table 90. Bio Basic Company Information Table 91. Bio Basic Business Overview Table 92. Bio Basic Gene Synthesis Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Bio Basic Gene Synthesis Product Portfolio Table 94. Bio Basic Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Gene Synthesis Product Image Figure 2. Global Gene Synthesis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Synthesis Market Size (2021-2032) & (US$ Million) Figure 4. Global Gene Synthesis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Below 1000 bp Image Figure 8. 1001-3000 bp Image Figure 9. 3001-5000 bp Image Figure 10. Above 5000 bp Image Figure 11. Global Gene Synthesis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Gene Synthesis Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Gene Synthesis Sales Value Share by Type (2021-2032) Figure 14. Commercial Research Image Figure 15. Academic Research Image Figure 16. Global Gene Synthesis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gene Synthesis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Gene Synthesis Sales Value Share by Application (2021-2032) Figure 19. Global Gene Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Gene Synthesis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Gene Synthesis Sales Value (2021-2032) & (US$ Million) Figure 22. North America Gene Synthesis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Gene Synthesis Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Gene Synthesis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Gene Synthesis Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Gene Synthesis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Gene Synthesis Sales Value (2021-2032) & (US$ Million) Figure 28. South America Gene Synthesis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Gene Synthesis Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Gene Synthesis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Gene Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Gene Synthesis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Gene Synthesis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Below 1000 bp
  • 1001-3000 bp
  • 3001-5000 bp
  • Above 5000 bp
Applications
  • Commercial Research
  • Academic Research
Companies covered
  • Genescript
  • GeneArt (Thermofischer)
  • IDT
  • DNA 2.0 (ATUM)
  • OriGene
  • BBI
  • Genewiz
  • Eurofins Genomics
  • Gene Oracle
  • SBS Genetech
  • Bio Basic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gene Synthesis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gene Synthesis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gene Synthesis Market Dynamics
  1. 2.1 Gene Synthesis Industry Trends
  2. 2.2 Gene Synthesis Industry Drivers
  3. 2.3 Gene Synthesis Industry Opportunities and Challenges
  4. 2.4 Gene Synthesis Industry Restraints
3 Gene Synthesis Market by Company
  1. 3.1 Global Gene Synthesis Company Revenue Ranking in 2025
  2. 3.2 Global Gene Synthesis Revenue by Company (2021-2026)
  3. 3.3 Global Gene Synthesis Company Ranking (2024-2026)
  4. 3.4 Global Gene Synthesis Company Manufacturing Base and Headquarters
  5. 3.5 Global Gene Synthesis Company Product Type and Application
  6. 3.6 Global Gene Synthesis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gene Synthesis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gene Synthesis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gene Synthesis Market by Type
  1. 4.1 Gene Synthesis Type Introduction
  2. 4.1.1 Below 1000 bp
  3. 4.1.2 1001-3000 bp
  4. 4.1.3 3001-5000 bp
  5. 4.1.4 Above 5000 bp
  6. 4.2 Global Gene Synthesis Sales Value by Type
  7. 4.2.1 Global Gene Synthesis Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gene Synthesis Sales Value by Type (2021-2032)
  9. 4.2.3 Global Gene Synthesis Sales Value Share by Type (2021-2032)
5 Gene Synthesis Market by Application
  1. 5.1 Gene Synthesis Application Introduction
  2. 5.1.1 Commercial Research
  3. 5.1.2 Academic Research
  4. 5.2 Global Gene Synthesis Sales Value by Application
  5. 5.2.1 Global Gene Synthesis Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gene Synthesis Sales Value by Application (2021-2032)
  7. 5.2.3 Global Gene Synthesis Sales Value Share by Application (2021-2032)
6 Gene Synthesis Regional Value Analysis
  1. 6.1 Global Gene Synthesis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gene Synthesis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gene Synthesis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gene Synthesis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gene Synthesis Sales Value (2021-2032)
  7. 6.3.2 North America Gene Synthesis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gene Synthesis Sales Value (2021-2032)
  10. 6.4.2 Europe Gene Synthesis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gene Synthesis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gene Synthesis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gene Synthesis Sales Value (2021-2032)
  16. 6.6.2 South America Gene Synthesis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gene Synthesis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gene Synthesis Sales Value Share by Country, 2025 VS 2032
7 Gene Synthesis Country-level Value Analysis
  1. 7.1 Global Gene Synthesis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gene Synthesis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gene Synthesis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gene Synthesis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gene Synthesis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gene Synthesis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gene Synthesis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gene Synthesis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gene Synthesis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gene Synthesis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gene Synthesis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gene Synthesis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gene Synthesis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gene Synthesis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gene Synthesis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gene Synthesis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gene Synthesis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gene Synthesis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gene Synthesis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gene Synthesis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gene Synthesis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gene Synthesis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gene Synthesis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gene Synthesis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gene Synthesis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gene Synthesis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gene Synthesis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gene Synthesis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gene Synthesis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gene Synthesis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gene Synthesis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gene Synthesis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gene Synthesis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gene Synthesis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gene Synthesis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genescript
  2. 8.1.1 Genescript Company Information
  3. 8.1.2 Genescript Business Overview
  4. 8.1.3 Genescript Gene Synthesis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genescript Gene Synthesis Product Portfolio
  6. 8.1.5 Genescript Recent Developments
  7. 8.2 GeneArt (Thermofischer)
  8. 8.2.1 GeneArt (Thermofischer) Company Information
  9. 8.2.2 GeneArt (Thermofischer) Business Overview
  10. 8.2.3 GeneArt (Thermofischer) Gene Synthesis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GeneArt (Thermofischer) Gene Synthesis Product Portfolio
  12. 8.2.5 GeneArt (Thermofischer) Recent Developments
  13. 8.3 IDT
  14. 8.3.1 IDT Company Information
  15. 8.3.2 IDT Business Overview
  16. 8.3.3 IDT Gene Synthesis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IDT Gene Synthesis Product Portfolio
  18. 8.3.5 IDT Recent Developments
  19. 8.4 DNA 2.0 (ATUM)
  20. 8.4.1 DNA 2.0 (ATUM) Company Information
  21. 8.4.2 DNA 2.0 (ATUM) Business Overview
  22. 8.4.3 DNA 2.0 (ATUM) Gene Synthesis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DNA 2.0 (ATUM) Gene Synthesis Product Portfolio
  24. 8.4.5 DNA 2.0 (ATUM) Recent Developments
  25. 8.5 OriGene
  26. 8.5.1 OriGene Company Information
  27. 8.5.2 OriGene Business Overview
  28. 8.5.3 OriGene Gene Synthesis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 OriGene Gene Synthesis Product Portfolio
  30. 8.5.5 OriGene Recent Developments
  31. 8.6 BBI
  32. 8.6.1 BBI Company Information
  33. 8.6.2 BBI Business Overview
  34. 8.6.3 BBI Gene Synthesis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BBI Gene Synthesis Product Portfolio
  36. 8.6.5 BBI Recent Developments
  37. 8.7 Genewiz
  38. 8.7.1 Genewiz Company Information
  39. 8.7.2 Genewiz Business Overview
  40. 8.7.3 Genewiz Gene Synthesis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genewiz Gene Synthesis Product Portfolio
  42. 8.7.5 Genewiz Recent Developments
  43. 8.8 Eurofins Genomics
  44. 8.8.1 Eurofins Genomics Company Information
  45. 8.8.2 Eurofins Genomics Business Overview
  46. 8.8.3 Eurofins Genomics Gene Synthesis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eurofins Genomics Gene Synthesis Product Portfolio
  48. 8.8.5 Eurofins Genomics Recent Developments
  49. 8.9 Gene Oracle
  50. 8.9.1 Gene Oracle Company Information
  51. 8.9.2 Gene Oracle Business Overview
  52. 8.9.3 Gene Oracle Gene Synthesis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gene Oracle Gene Synthesis Product Portfolio
  54. 8.9.5 Gene Oracle Recent Developments
  55. 8.10 SBS Genetech
  56. 8.10.1 SBS Genetech Company Information
  57. 8.10.2 SBS Genetech Business Overview
  58. 8.10.3 SBS Genetech Gene Synthesis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SBS Genetech Gene Synthesis Product Portfolio
  60. 8.10.5 SBS Genetech Recent Developments
  61. 8.11 Bio Basic
  62. 8.11.1 Bio Basic Company Information
  63. 8.11.2 Bio Basic Business Overview
  64. 8.11.3 Bio Basic Gene Synthesis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bio Basic Gene Synthesis Product Portfolio
  66. 8.11.5 Bio Basic Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst